Patents by Inventor Andrew Dore

Andrew Dore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease
    Patent number: 6764843
    Abstract: The present invention relates to recombinant DNA that encodes the BsmBI restriction endonuclease as well as BsmBI methyltransferase, expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli cells containing the recombinant DNA. It also relates to a method for purification of the recombinant BsmBI restriction endonuclease.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: July 20, 2004
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Andrew Dore, Adam Hume, John Pelletier, Jing Zhou
  • Method for cloning and expression of TspRI restriction endonuclease and TspRI methylase in E. coli
    Patent number: 6589769
    Abstract: The present invention relates to recombinant DNA that encodes the TspRI restriction endonuclease as well as TspRI methylase, expression of TspRI restriction endonuclease and TspRI methylase in E. coli cells containing the recombinant DNA.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: July 8, 2003
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, Andrew Dore, Michael Dalton, Jack Benner
  • Method for cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease
    Publication number: 20030100052
    Abstract: The present invention relates to recombinant DNA that encodes the BsmBI restriction endonuclease as well as BsmBI methyltransferase, expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli cells containing the recombinant DNA. It also relates to a method for purification of the recombinant BsmBI restriction endonuclease.
    Type: Application
    Filed: September 28, 2001
    Publication date: May 29, 2003
    Applicant: New England Biolabs
    Inventors: Shuang-Yong Xu, Andrew Dore, Adam Hume, John Pelletier, Jing Zhou